Simplex Trading
RXDX

Simplex Trading’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Simplex Trading’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,000
Closed -$113K – 10363
2023
Q2 		$113K Sell
7,000
-32,900
-82% -$5.96M ﹤0.01% 4941
2023
Q1 		$4.28M Sell
39,900
-105,100
-72% -$12.1M ﹤0.01% 1401
2022
Q4 		$15.9M Buy
145,000
+87,300
+151% +$5.66M 0.02% 638
2022
Q3 		$3.4M Buy
57,700
+57,600
+57,600% +$2.64M ﹤0.01% 1500
2022
Q2 		$2K Sell
100
-3,300
-97% -$95.6K ﹤0.01% 9481
2022
Q1 		$128K Sell
3,400
-600
-15% -$23.7K ﹤0.01% 5809
2021
Q4 		$158K Buy
+4,000
New +$125K ﹤0.01% 5521

Simplex Trading's RXDX Position: Q2 2023 in Review

Simplex Trading sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 758 shares — an estimated $137K sold.

Simplex Trading first reported a position in RXDX in Q2 2022 and held it in 2 quarters. The position peaked at $323K in Q2 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

  • Simplex Trading reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 758 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $137K.
  • Simplex Trading first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Simplex Trading's Prometheus Biosciences, Inc. Common Stock position peaked at $323K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.